Tramadol Classification: Tramadol (Tramadol) GARANT

Tramadol Classification: Tramadol (Tramadol) GARANT

Content:

Tramadol Classification: Tramadol (Tramadol) GARANT

Tramadol (Tramadol) | GUARANTOR

Tramadol Class: the right technique, typical mistakes

Tramadol (Tramadol)

Side effects:

DROPS:

Classification of the incidence of side effects (WHO):

very often> 1/10

often from> 1/100 to < 1/10

infrequently from> 1/1000 to < 1/100

rarely from> 1/10000 to < 1/1000

very rarely from < 1/10000, включая отдельные сообщения.

– From the central and peripheral nervous system:

Very often: dizziness;

Often: headache;

Infrequently: anxiety, confusion, drowsiness;

Seldom: euphoria, emotional instability, sleep disturbance, nightmares, cognitive disorders, hallucinations, amnesia; impaired coordination, convulsions, paresthesia, tremor, impaired concentration, epileptiform seizures, with prolonged use – the development of drug dependence;

Very rarely: panic attacks, ringing in the ears;

– Since the cardiovascular system:

Rarely: tachycardia, palpitations, cardiovascular collapse, syncope, orthostatic hypotension, cardiovascular insufficiency;

Very rare: bradycardia, arterial hypertension;

– On the part of the respiratory system:

Rarely: shortness of breath, respiratory depression, pulmonary edema;

– From the senses:

Very rarely: reduced visual acuity, sometimes mydriasis, a violation of taste;

– From the digestive system:

Very often: nausea;

Often: vomiting, constipation or diarrhea, dryness of the oral mucosa;

Infrequently: dyspepsia, abdominal pain, bloating;

Rarely: difficulty swallowing;

– Very rarely: increased activity of liver transaminases;

– From the skin:

Often: sweating;

Infrequently: skin rash, skin itch;

Rarely: urticaria;

– From the genitourinary system:

Infrequently: urinary retention, increased frequency of urination, violation

menstrual tramadol classification: cycle, signs of menopause;

Seldom: dysuria;

– From the musculoskeletal system:

Seldom: muscular weakness;

– Metabolism:

Infrequently: anorexia;

Seldom: decrease in body weight;

Allergic reactions:

Rarely: allergic reactions, manifested by dyspnea, bronchospasm, wheezing, as well as angioedema.

Other: with long-term use – drug dependence; with abrupt cancellation – “cancellation” syndrome.

CASCULAS:

The most frequent adverse reactions are nausea and dizziness, noted in more than 10% of patients.

The frequency is determined as follows:

Very often:> 1/10;

Often:> 1/100 < 1/10;

Infrequently:> 1/1000 < 1/100;

Rarely:> 1/10 000 < 1/1000;

Very rarely: <1/10000;

Not enough data: can not be determined based on available

data.

-Violations of the cardiovascular system:

Infrequently: effect on cardiovascular regulation (palpitations, tachycardia, orthostatic hypotension or collapse). These side effects are mainly observed with intravenous administration of the drug or with significant physical exertion.

Rarely: bradycardia, increased blood pressure.

-Metabolic and nutritional disorders:

Seldom: changes in appetite.

-Respiratory disorders:

Rarely: respiratory depression, shortness of breath.

With a significant excess of the recommended doses with the simultaneous use of other drugs that depress the central nervous system (CNS), respiratory depression is possible.

Worsening of the condition in bronchial asthma was noted, however, tramadol classification is causative: – no investigative connection with the use of the drug was established.

-Nervous system disorders:

Very often: dizziness.

Often: headache, drowsiness.

Rarely: speech disorders, paresthesia, tremor, epileptiform seizures, involuntary muscle contractions, impaired coordination, syncope. Epileptiform seizures are possible after the use of high doses of tramadol and with simultaneous use with drugs that lower the threshold of convulsive readiness.

– Mental Disorders:

Rarely: hallucinations, confusion, sleep disturbances, anxiety, delirium, and nightmares. After the use of tramadol, various rarely observed undesirable reactions from the psyche are possible (depending on the patient’s personality and the duration of treatment). These side effects include mood changes (usually tramadol classification: euphoria, sometimes dysphoria), activity changes (usually decrease, sometimes increase), impaired cognitive functions and perceptions (for example, decision-making, perception disorders).

Perhaps the development of drug dependence.

– Violations by the organ of vision:

Rarely: miosis, mydriasis, blurred vision.

– Disorders of the gastrointestinal tract:

Very often: nausea.

Often: constipation, dry mouth, vomiting.

Infrequently: emetic desires, a feeling of heaviness in the epigastrium, flatulence, diarrhea.

– Violations of the skin and subcutaneous tissues:

Often: sweating.

Infrequently: itch, rash, urticaria.

How to make a perfect body: the secrets of Tramadol Class

– Disorders of the musculoskeletal and connective tissue:

Seldom: muscular weakness.

– Disorders of the liver and biliary tract:

In some cases, there was an increase in the activity of liver enzymes, which coincided in time with the therapy with tramadol.

– On the part of the kidneys and urinary system:

Rarely: urination disorders (difficulty urinating, dysuria and urinary retention).

– Immune system disorders:

Rarely: allergic reactions (shortness of breath, bronchospasm, wheezing, angioedema) and anaphylaxis.

– Common disorders:

Often: fatigue.

Seldom: the possible cancellation symptoms are similar to the opioid withdrawal symptoms: agitation, anxiety, nervousness, sleep disturbances, hyperkinesia, tremor, and gastrointestinal symptoms.

Other symptoms that are very rare with the abolition of tramadol include: panic attacks, severe anxiety, hallucinations, paresthesias, tinnitus and other extremely rare symptoms from the central nervous system (confusion, hallucinations, depersonalization, derealization, paranoia).

If the side effects indicated in the instruction have occurred, or other side effects that are not indicated in the instruction are noticed, inform your doctor about it.

INJECTION:

Classification of the incidence of side effects (WHO):

very often> 1/10

often from> 1/100 to < 1/10

infrequently from> 1/1000 to < 1/100

rarely from> 1 / 10,000 to < 1/1000

very rarely from < 1/10000, включая отдельные сообщения.

-Since the cardiovascular system:

Infrequently: disturbances of cardiovascular regulation (palpitations, tachycardia, postural hypotension or collapse).

These adverse effects may occur, after intravenous administration and in patients of physical exertion.

Rarely: bradycardia, fainting, high blood pressure.

-From the nervous system:

Very often: dizziness.

Often: headache, drowsiness.

Rarely: changes in appetite, speech disorders, paresthesia, depression, amnesia, tremor, respiratory depression, epileptiform seizures, involuntary muscle contractions, impaired coordination, instability of gait, blurred vision, fainting, weakness, fatigue, paradoxical stimulation of the central nervous system, sweating.

Convulsions are possible after the use of high doses of tramadol and with simultaneous use with drugs that reduce the threshold of convulsive readiness.

-From the psyche:

Rarely: hallucinations, confusion, sleep disturbance, anxiety, delirium,

anxiety and nightmares.

After the use of tramadol, various rarely observed undesirable reactions from the psyche are possible (depending on the patient’s personality and the duration of treatment). These undesirable drug reactions include a change in mood (usually euphoria, sometimes dysphoria), a change in motor activity (usually a decrease, sometimes an increase), impaired cognitive functions and perceptions (for example, a decision-making process, disorders of perception). Perhaps the development of drug dependence. Possible withdrawal symptoms are similar to opioid withdrawal symptoms: agitation, anxiety, nervousness, sleep disturbances, hyperkinesia, tremors, and gastrointestinal symptoms. Other symptoms that are very rare with the abolition of tramadol include: panic attacks, severe anxiety, hallucinations, paresthesias, tinnitus and other very rare symptoms from the CNS tramadol classification: (disruption of orientation in time and space, hallucinations, depersonalization, derealization, paranoia).

-On the part of the organ of vision:

Rarely: blurred vision, miosis;

Unknown: mydriasis.

-On the part of the respiratory system:

Rarely: shortness of breath.

With a significant excess of the recommended doses with the simultaneous use of other drugs that depress the central nervous system (CNS), respiratory depression is possible.

It was noted the deterioration of bronchial asthma, however, a causal relationship with the use of the drug is not installed.

-From the digestive system:

Very often: nausea.

Often: vomiting, constipation, dry mouth.

Infrequently: emetic urges, a feeling of heaviness in eggshgastriya, flatulence, diarrhea.

Very rare: pain in the abdomen, difficulty in swallowing.

-From the skin and subcutaneous tissue:

Often: sweating.

Infrequently: skin reactions (eg, itching, rash, urticaria).

-From the musculoskeletal system:

Seldom: muscular weakness.

-Liver and biliary tract:

In some cases, there was an increase in the activity of microsomal liver enzymes in time coinciding with the therapy with Gramadol.

-On the part of the kidneys and urinary system:

Rarely: urination disorders (difficulty urinating, dysuria and urinary retention).

On the part of the immune system:

Rarely: allergic reactions (shortness of breath, bronchospasm, wheezing, angioedema) and anaphylaxis.

-Metabolism:

Frequency unknown: hypoglycemia.

– Common disorders:

Often: increased fatigue.

RECTAL SUPPOSITORIES:

Tramadol Classification: technique and types of squats

Classification of the incidence of side effects (WHO):

very often> 1/10

often from> 1/100 to < 1/10

infrequently from> 1/1000 to < 1/100

rarely from> 1/10000 to < 1/1000

very rarely from < 1/10000, включая отдельные сообщения.

-From the central and peripheral nervous system:

Very often: dizziness;

Often: headache;

Infrequently: anxiety, confusion, drowsiness;

Seldom: euphoria, emotional instability, nightmares, cognitive disorders, hallucinations, amnesia; impaired coordination of movements, convulsions, paresthesias; tremor, concentration disorders, epileptiform seizures, with prolonged use – the development of drug dependence;

Very rarely: panic attacks, ringing in the ears;

-Since the cardiovascular system:

Rarely: tachycardia, palpitations, cardiovascular collapse, syncope, orthostatic hypotension, cardiovascular insufficiency;

Very rarely: bradycardia, increased blood pressure;

-On the part of the respiratory system:

Rarely: shortness of breath, respiratory depression, pulmonary edema;

-From the senses:

Very rarely: reduced visual acuity, sometimes mydriasis, a violation of taste;

-From the digestive system:

Very often: nausea;

Often: vomiting, constipation or diarrhea, dryness of the oral mucosa;

Infrequently: dyspepsia, abdominal pain, bloating;

Rarely: difficulty swallowing;

Very rarely: increased activity of liver transaminases;

-From the skin:

Often: sweating;

-From the genitourinary system:

Infrequently: urinary retention, increased frequency of urination, irregular menstruation, signs of menopause;

Seldom: dysuria;

-From the musculoskeletal system:

Seldom: muscular weakness;

-Metabolism:

Infrequently: anorexia;

Seldom: decrease in body weight;

-Allergic reactions:

Seldom: allergic reactions (for example, urticaria, pruritus, rash, bullous rash, angioedema) and anaphylaxis, which can cause azole dyes E122, E124 and E151.

Other: with long-term use – drug dependence; with abrupt cancellation – “cancellation” syndrome.

Leave a Reply

Your email address will not be published. Required fields are marked *